Filing Details
- Accession Number:
- 0000950170-25-005576
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-14 21:13:22
- Reporting Period:
- 2025-01-10
- Accepted Time:
- 2025-01-14 21:13:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1534969 | Sera Prognostics Inc. | SERA | Services-Medical Laboratories (8071) | 261911522 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779964 | Benjamin Jackson | C/O Sera Prognostics, Inc. 2749 East Parleys Way, Suite 200 Salt Lake City UT 84109 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2025-01-10 | 12,041 | $7.36 | 129,704 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2025-01-10 | 1,231 | $8.05 | 128,473 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2025-01-13 | 7,912 | $6.38 | 120,561 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2025-01-14 | 8,407 | $6.20 | 112,154 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.99 to $7.95, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Includes 4,785 and 1,432 shares of Class A Common Stock purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase periods of December 1, 2023 to May 31, 2024 and June 3, 2024 to November 30, 2024, respectively.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.13, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.11 to $6.72, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.03 to $6.44, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
